Improvement in accuracy of delayed recall in aged and non-aged, mature monkeys after intramuscular or transdermal administration of the CNS nicotinic receptor agonist ABT-418

Psychopharmacology

Volumn 130, Issue 3, 1997, Pages 276-284

  Prendergast, Mark A ^a,b   Terry Jr , Alvin V ^a   Jackson, William J ^a   Marsh, Kennan C ^c   Decker, Michael W ^c   Arneric, Stephen P ^c   Buccafusco, Jerry J ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c ABBOTT LABORATORIES   (United States)

Author keywords

aging; cognition; delayed recall; memory; monkeys; nicotine; transdermal

Indexed keywords

3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE; NICOTINIC AGENT;

ACCURACY; AGED; AGING; ANIMAL EXPERIMENT; ARTICLE; COGNITION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; FEMALE; INSTRUMENTAL CONDITIONING; INTRAMUSCULAR DRUG ADMINISTRATION; MACACA; MALE; MEMORY; MONKEY; NONHUMAN; PRIORITY JOURNAL; TASK PERFORMANCE; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; AGING; ANTI-ANXIETY AGENTS; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; ISOXAZOLES; MALE; MENTAL RECALL; PYRROLIDINES; TIME FACTORS;

EID: 0030981799     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050240     Document Type: Article

References (34)

1. Araujo DM, Lapchak PA, Robitaille Y, Gauthier S, Quirion R (1988) Differential alterations of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. J Neurochem 50: 1914-1923
2. Arendash GW, Sanberg PR, Sengtock GJ (1995) Nicotine enhances the learning and memory of aged rats. Pharmacol Biochem Behav 52[1]:517-523
3. Arendt T, Bigl V, Tennstedt A, Arendt A (1985) Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease. Neuroscience 14: 1-14
4. Arneric SP, Sullivan JP, Briggs CA, Donnelly-Roberts D, Anderson DJ, Raszkiewicz JL, Hughes M, Cadman ED, Adams P, Garvey DS, Wasicak J, Williams W (1994) ABT-418: a novel cholinergic ligand with cognition enhancing and anxiolytic activities I: in vitro characterization. J Pharmacol Exp Ther 270: 310-318
5. Arneric SP, Anderson DJ, Bannon AW, Briggs CA, Buccafusco JJ, Brioni JD, Cannon JB, Decker MW, Donnelly-Roberts D, Gopalakrishnan M, Holladay MW, Kyncl J, Marsh KC, Pauly J, Radek RJ, Rodriques AD, Sullivan JP (1995) Preclinical pharmacology of ABT- 418: a prototypical cholinergic channel activator for the treatment of Alzheimer's disease. CNS Drug Rev 1[1]: 1-26
6. Bartus RT, Dean RLI, Beer B, Lipps AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408-417
7. Benowitz NL (1992) Nicotine and coronary heart disease. Trends Cardiovasc Med 1: 315-321
8. Buccafusco JJ, Jackson WJ (1991) Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in the young and aged monkey. Neurobiol Aging 12: 233-238
9. Buccafusco JJ, Jackson WJ, Gattu M, Terry Jr AV (1995a) Isoarecolone-induced enhancement of delayed matching to sample performance in monkeys: role of nicotinic receptors. Neuroreport 6: 1223-1227
10. Buccafusco JJ, Jackson WJ, Terry AV, Marsh KC, Decker MW, Arneric SP (1995b) Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: a novel cholinergic channel activator tor memory enhancement Psychopharmacology 120: 256-266
11. Decker MW, Brioni J, Sullivan JP, Buckley M, Radek R, Raskiewicz JL, Hughes M, Giardini W, Wasicak JT, Garvey DS, Williams M, Arneric SP (1994) ABT-418: a novel cholinergic ligand with cognition enhancing and anxiolytic activities: II. In vivo characterization. J Pharmacol Exp Ther 270: 319-328
12. Decker MW, Majchrzak MJ (1992) Effects of systemic and intracerebroventricular administration of mecamylainine a nicotinic cholinergic antagonist on spatial memory in rats. Psychopharmacology 107: 530-539
13. Decker MW, Majchrzak MJ, Anderson DJ (1992) Effects of nicotine on spatial memory deficits in rats with septal lesions. Brain Res 572: 281-285
14. Elrod K, Buccafusco JJ, Jackson WJ (1988) Nicotine enhances delayed matching-to-sample performance in primates. Life Sci 43: 277-287
15. 3H] nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal. J Neurochem 47: 1948-1954
16. Garvey DS, Wasicak J, Decker MW, Brioni JD, Sullivan JP, Carrera GM, Holladay MH, Arneric SP, Williams M (1994) Novel isoxazoles which interact with brain cholinergic channel receptors that have intrinsic cognitive enhancing and anxiolytic activities. J Med Chem 37: 1055-1059
17. Jones GMM, Sahakian BJ, Levy R, Warburton DM, Gray JA (1992) Effects of acute subcutaneous nicotine on attention information processing and short-term memory in Alzheimer's disease. Psychopharmacology 108: 485-494
18. Levin ED (1992) Nicotinic systems in cognitive function. Psychopharmacology 108: 417-431
19. Levin ED, Lee C, Rose JE, Reyes A, Ellison G, Jaravik M, Gritz E (1990) Chronic nicotine and withdrawal effects on radial-arm performance in rats. Behav Neural Biol 53: 269-276
20. Morris RGM (1984) Development of a water-maze procedure for studying spatial learning in the rat. J Neurosci Meth 11: 47-60
21. Newhouse PA, Potter A, Corwin J (1996) Acute administration of the cholinergic channel activator abt-418 improves learning in Alzheimer's disease. Annual Conference of the Society for Research on Nicotine and Tobacco, Washington, D.C.
22. Newhouse PA, Sunderland T, Tariot PN, Blumhardt CL, Weingartner H, Mellow A, Murphy DL (1988) Intravenous nicotine in Alzheimer's disease: a pilot study. Psychopharmacology 95: 71-75
23. 3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains. Neurosci Lett 72: 115-119
24. Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. BMJ 2: 1457-1459
25. Quirion R, Martel JC, Robitaille Y, Etienne P, Wood P, Nair NPV, Gauthier S (1986) Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type. Can J Neurol Sci 13: 503-510
26. Ridley RM, Murray TK, Johnson JA, Baker HF (1986) Learning impairment following lesion of the basal nucleus of Meynert in the marmoset: modification by cholinergic drugs. Brain Res 376: 108-116
27. Ridley RM, Baker HF, Drewett B (1987) Effects of arecoline and pilocarpine on learning ability in marmosets pretreated with hemicholinium-3. Psychopharmacology 91: 512-514
28. Riekkinen P, Sirvi J, Aaltonen M, Riekkinen P (1990) The effects of concurrent manipulations of nicotinic and muscarinic receptors on spatial and passive avoidance learning. Pharmacol Biochem Behav 37: 405-410
29. Sahakian B, Jones G, Levy R, Gray J, Warburton D (1989) The effects of nicotine on attention information processing and short-term memory in patients with dementia of the Alzheimer's type. Br J Psychiatry 154: 797-800
30. Schroder H, Biacobini E, Struble RG, Zilles K, Maelieke A (1991) Nicotinic cholinoceptive neurons of the frontal cortex are reduced in Alzheimer's disease. Neurobiol Aging 12: 259-262
31. Terry AV Jr, Buccafusco JJ, Jackson WJ (1993) Scopolamine reversal of nicotine enhanced delayed matching-to-sample performance by monkeys. Pharmacol Biochem Behav 45: 925-929
32. Terry AV Jr, Buccafusco JJ, Jackson WJ, Zagrodnik S, Evans-Martin FF, Decker MW (1996) Effects of stimulation or blockade of central nicotinic-cholinergic receptors on performance of a novel version of the rat stimulus discrimination task. Psychopharmacology 123: 172-181
33. Walker LC, Masters C, Beyreuther K, Price DL (1990) Amyloid in the brains of aged squirrel monkeys. Acta Neuropathol 80: 381-387
34. Wisniewski HM, Ghetti B, Terry RD (1973) Neuritic (senile) plaques and filamentous changes in aged rhesus monkeys. J Neuropathol Exp Neurol 32: 566-584